Aura Biosciences Inc Strategic Asset Allocation Index
Aura Biosciences Inc strategic asset allocation index. Aura Biosciences Inc (AURA) has a Strategic Asset Allocation Index of 3.0% as of June 2023. Strategic assets (PP&E of $5.06 Million plus long-term investments of $-) total $5.06 Million, measured against net assets of $166.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Aura Biosciences Inc (AURA) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Aura Biosciences Inc (2019–2022)
Strategic asset allocation index of Aura Biosciences Inc from 2019 to 2022. This chart shows how Aura Biosciences Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 3.0%, representing strategic assets of $5.06 Million against net assets of $166.44 Million USD.
Aura Biosciences Inc Strategic Asset Allocation Index by Year (2019–2022)
Aura Biosciences Inc strategic asset allocation index by year from 2019 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Aura Biosciences Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AURA market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 2.7% | $5.37 Million | $5.37 Million | $- | $195.58 Million | ▼ -0.7 pp |
| 2021 | 3.4% | $5.25 Million | $5.25 Million | $- | $152.31 Million | ▼ -15.0 pp |
| 2020 | 18.5% | $3.57 Million | $3.57 Million | $- | $19.36 Million | ▲ +6.6 pp |
| 2019 | 11.8% | $3.63 Million | $3.63 Million | $- | $30.76 Million | — |